sunitinib sandoz 12,5 mg hard caps.
sandoz sa-nv - sunitinib 12,5 mg - capsule, hard - 12,5 mg - sunitinib 12.5 mg - sunitinib
sunitinib sandoz 25 mg hard caps.
sandoz sa-nv - sunitinib 25 mg - capsule, hard - 25 mg - sunitinib 25 mg - sunitinib
sunitinib sandoz 50 mg hard caps.
sandoz sa-nv - sunitinib 50 mg - capsule, hard - 50 mg - sunitinib 50 mg - sunitinib
sunitinib sandoz 12.5 mg
novartis israel ltd - sunitinib - hard capsule - sunitinib 12.5 mg - sunitinib - sunitinib sandoz is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sunitinib sandoz is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
sunitinib sandoz 25 mg
novartis israel ltd - sunitinib - hard capsule - sunitinib 25 mg - sunitinib - sunitinib sandoz is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sunitinib sandoz is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
sunitinib sandoz 50 mg
novartis israel ltd - sunitinib - hard capsule - sunitinib 50 mg - sunitinib - sunitinib sandoz is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sunitinib sandoz is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
sunitinib sandoz 12,5 mg hard caps.
sandoz sa-nv - sunitinib 12,5 mg - capsule, hard - sunitinib
sunitinib sandoz 25 mg hard caps.
sandoz sa-nv - sunitinib 25 mg - capsule, hard - sunitinib
sunitinib sandoz 50 mg hard caps.
sandoz sa-nv - sunitinib 50 mg - capsule, hard - sunitinib
sunitinib medichem 12.5mg hard capsules
medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents